A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Summary

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. Additional information is available at www.SOLAIRIA.com.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Severe Asthma

Eligibility basics and study details

Study type

Interventional

Phase

Phase 3

Ages

12 to 80 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

Generate Biomedicines

Last updated on ClinicalTrials.gov

October 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites